NIH-funded research R01 grant

Investigating how inflammation affects motivation in schizophrenia patients

Official title: Targeting Inflammation-Induced Changes in Brain Reward Signaling and Motivational Deficits in Patients with Schizophrenia Using an Anti-Inflammatory Challenge

Funded at Emory University · NIH-11003764 · Data updated 2026-11-12

This study is looking at how inflammation might affect motivation in people with schizophrenia, and it will test if a medication that reduces inflammation can help improve motivation and daily functioning.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMarch 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$497,418
NIH project number5R01MH131910-03
Project IDNIH-11003764 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with schizophrenia who experience motivational deficits and negative symptoms.

Less likely to help

Patients who do not have schizophrenia or those without significant motivational deficits may not benefit from this research.

What this research studies

This research explores the connection between inflammation and motivational deficits in individuals with schizophrenia. It focuses on how elevated levels of inflammatory markers, particularly tumor necrosis factor (TNF), may disrupt brain areas involved in reward processing, leading to negative symptoms and poor treatment responses. By administering an anti-inflammatory agent, the study aims to determine if reducing inflammation can improve motivation and overall functioning in these patients. Participants will undergo assessments to evaluate changes in brain activity and motivational behaviors in response to treatment.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies that enhance motivation and improve quality of life for patients with schizophrenia.

How similar studies have gone: Previous research has indicated that targeting inflammation may improve symptoms in related conditions, suggesting potential for success in this approach.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Goldsmith, David Ryan — Emory University
  • Study coordinator: Goldsmith, David Ryan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.